AZN - AstraZeneca: Our Next Growth Pick May, 03 2022 10:52 PM AstraZeneca PLC After the Alexion maxi-acquisition, the company beat both revenue and EPS consensus. Premium pipelines deserve a premium valuation. 2022 guidance confirmed. For further details see: AstraZeneca: Our Next Growth Pick